Wolfgang Wurst
Corporate Officer/Principal bei Technische Universität München
Profil
Wolfgang Wurst is the founder of Affectis Pharmaceuticals AG, which was founded in 2004.
He held the title of Director-Supervisory Board.
Currently, he is a Professor at Technische Universität München and the Head-Molecular Neurogenetics Group at Helmholtz Zentrum München.
In the past, he worked as the Leader-Molecular Neurogenetics at Max-Planck Institute of Psychiatry.
Dr. Wurst received his undergraduate degree from the University of Freiburg and his doctorate from the University of Gottingen.
Aktive Positionen von Wolfgang Wurst
| Unternehmen | Position | Beginn |
|---|---|---|
| Technische Universität München | Corporate Officer/Principal | - |
Helmholtz Zentrum München
 Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Wolfgang Wurst
| Unternehmen | Position | Ende |
|---|---|---|
| Max-Planck Institute of Psychiatry | Corporate Officer/Principal | - |
Affectis Pharmaceuticals AG
 Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Gründer | - |
Ausbildung von Wolfgang Wurst
| University of Freiburg | Undergraduate Degree |
| University of Gottingen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Affectis Pharmaceuticals AG
Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Health Technology |
Helmholtz Zentrum München
Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Commercial Services |
| Max-Planck Institute of Psychiatry |
